Market Snapshot

BSE Sensex: 83576.24 -0.72%
BSE 500: 36807.62 -0.89%
BSE 200: 11620.53 -0.79%
BSE 100: 26904.82 -0.73%
BSE MidCap: 46304.8 -0.90%
BSE SmallCap: 49912.11 -1.74%
BSE BANKEX: 66616.92 -0.58%
BSE IT: 36795.24 0.03%
Nifty 50: 25683.3 -0.75%
Nifty 500: 23467.35 -0.90%
Nifty 200: 14306.95 -0.79%
Nifty 100: 26252.95 -0.79%
Nifty Midcap 100: 59748.15 -0.79%
Nifty Small 100: 17282.65 -1.81%
Nifty IT: 38027.2 0.28%
Nifty PSU Bank: 8601.05 0.18%

News:

Protean eGov Technologies bags...
PTC Industries? arm secures ma...
Globus Spirits reports multi-f...
IREDA Q3 PAT jumps 15% YoY to ...
Tejas Networks reports dismal ...

Senores Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

09 Jan 2026 | 03:59 PM

813.40

-7.35 (-0.90%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

53.24%

Return (1Y)

Beaten BSE Healthcare by 55.69%
More Volatile

3.12%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.16%
Consistent Performer

8/12

Months

beaten BSE Healthcare
AxisDirect View

No View

52 Week High-Low

876

440

News & Announcements

Senores Pharmaceuticals EGM scheduled
4 days ago

Senores Pharmaceuticals EGM scheduled

08 - Jan - 2026 12:00 | 4 days ago

Senores Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 January 2026.
Powered by Capital Market - Live News
Senores Pharmaceuticals to conduct board meeting
7 days ago

Senores Pharmaceuticals to conduct board meeting

05 - Jan - 2026 12:00 | 7 days ago

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 January 2026.
Powered by Capital Market - Live News
Senores Pharma inks SPA for Apnar Pharma takeover
27 days ago

Senores Pharma inks SPA for Apnar Pharma takeover

16 - Dec - 2025 12:00 | 27 days ago

Apnar Pharma is a pharmaceutical company primarily engaged in the business of manufacture of generic pharmaceutical formulations, having US FDA, UK-MHRA and Health Canada approved manufacturing facility near Vadodara, Gujarat. Its turnover was Rs 14.21 crore in FY25.
The acquisition will be completed in two tranches, with a first tranche involving the acquisition of 75% stake, expected to be completed in current fiscal by March 2026. The remaining 25% stake is expected to be completed by Q2 of FY 2027.
The company will acquire entire stake at total enterprise value of approximately Rs 91 crore. Of this, around Rs 76 crore represents debt and assumed liabilities related to the manufacturing facility, while the balance of about Rs 15 crore will be paid in cash.
Senores Pharmaceuticals (Senores) is a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms.
The pharmaceutical company?s consolidated net profit surged 152.18% YoY to Rs 32.28 crore in Q2 FY26. Revenue from operations jumped 56.08% YoY to Rs 153.36 crore in Q2 FY26.
The scrip rose 0.17% to Rs 816.90 on the BSE.
Powered by Capital Market - Live News
Senores Pharmaceuticals consolidated net profit rises 152.18% in the September 2025 quarter
67 days ago

Senores Pharmaceuticals consolidated net profit rises 152.18% in the September 2025 quarter

06 - Nov - 2025 12:00 | 67 days ago

Net profit of Senores Pharmaceuticals rose 152.18% to Rs 32.38 crore in the quarter ended September 2025 as against Rs 12.84 crore during the previous quarter ended September 2024. Sales rose 56.08% to Rs 153.36 crore in the quarter ended September 2025 as against Rs 98.26 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 153.36 98.26 56

OPM % 32.28 23.68 -

PBDT 48.73 19.86 145

PBT 40.64 15.97 154

NP 32.38 12.84 152

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Senores Pharmaceuticals Ltd has increased by 16.83% since past 3 Months
MF shareholding in Senores Pharmaceuticals Ltd has increased by 17.99% since past 3 Months
FII shareholding in Senores Pharmaceuticals Ltd has decreased by -22.3% since past 1 Year
MF shareholding in Senores Pharmaceuticals Ltd has decreased by -37.1% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	153.36	98.26	56
OPM %	32.28	23.68	-
PBDT	48.73	19.86	145
PBT	40.64	15.97	154
NP	32.38	12.84	152

General Notifications

My Notifications

Research Notifications

Senores Pharmaceuticals Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

813.40 -7.35 (-0.90%)

News & Announcements

Price vs Volume

Stock Trivia

Senores Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

813.40

-7.35 (-0.90%)